fda approved indications for semaglutide A New Indication Semaglutide (Wegovy) https://t.co/3IRTEv70jU Semaglutide ( Wegovy FDA Approval: CV Risk

Although these studies demonstrated how GLP-1 agonists can worsen diabetic gastroparesis and specifically advised against using GLP-1 agonist therapy in people with similar symptoms, Novo Nordisk failed to inform doctors about this potential issue and did not alter their prescribing or dosage recommendations

Di Conza G, Tsai C-H, Gallart-Ayala H, Yu Y-R, Franco F, Zaffalon L, et al

Retatrutide is arguably the next step

Although the use of pharmaceutical treatment has saved lives, Life Extension has long recognized that optimal cardiovascular protection involves a multifactorial strategy that includes at least 17 different factors responsible for vascular disease